Liver fibrosis in HIV-infected patients with chronic hepatitis B extensively exposed to antiretroviral therapy with anti-HBV activity

HIV Clinical Trials

Volumn 7, Issue 5, 2006, Pages 246-250

  Maida, Ivana ^a,b   Soriano, Vincent ^a   Castellares, Carol ^a   Ramos, Belén ^a   Sotgiu, Giovanni ^b   Martin Carbonero, Luz ^a   Barreiro, Pablo ^a   Rivas, Pablo ^a   González Lahoz, Juan ^a   Núñez, Marina ^a,c  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b UNIVERSITY OF SASSARI   (Italy)

^c WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

Author keywords

HBV; HIV; Liver fibrosis; Transient elastography

Indexed keywords

ALANINE AMINOTRANSFERASE; AMINOTRANSFERASE; ANTIRETROVIRUS AGENT; ASPARTATE AMINOTRANSFERASE; LAMIVUDINE; TENOFOVIR;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIVIRAL ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DRUG EXPOSURE; ELASTOGRAPHY; FEMALE; HEPATITIS B; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER FIBROSIS; MALE; PREDICTION; PRIORITY JOURNAL; SCORING SYSTEM;

EID: 33845692257     PISSN: 15284336     EISSN: None     Source Type: Journal    
DOI: 10.1310/hct0705-246     Document Type: Article

References (15)

1. Colin J, Cazals-Hatem D, Loriot A, et al. Influence of HIV infection on chronic hepatitis B in homosexual men. Hepatology. 1999;29:1306-1310.
2. Thio C, Seaberg E, Skolasky R, et al. HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter AIDS Cohort Study (MACS). Lancet. 2002;360:1921-1926.
3. Bonacini M, Bzowej N, Louie S, Wohl AR. Survival in patients with HIV infection and viral hepatitis B or C. AIDS. 2004;18:2039-2045.
4. Cadranel J, Rufat P, Degos F. Practices of liver biopsy in France: results of a prospective nationwide survey. Hepatology. 2000;32:477-481.
5. Zeng M, Lu L, Mao Y, et al. Prediction of significant fibrosis in HBeAg-positive patients with chronic hepatitis B by a non-invasive model. Hepatology. 2005;42:1437-1445.
6. Sandrin L, Fourquet B, Hasquenoph J, et al. Transient elastography: a new non-invasive method for assessment of hepatic fibrosis. Ultrasound Med Biol. 2003;29:1705-1713.
7. Ziol M, Handra-Luca A, Kettaneh A, et al. Non-invasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology. 2005;41(1):48-54.
8. Castera L, Vergniol J, Foucher J, et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology. 2005;128:343-350.
9. Colletta C, Smirne C, Fabris C, et al. Value of two non-invasive methods to detect progression of fibrosis among HCV carriers with normal aminotransferases. Hepatology. 2005;42:838-845.
10. Núñez M, Diaz-Pollan B, Camino N et al. Virological outcome of chronic hepatitis B virus infection in HIV-coinfected patients receiving anti-HBV active antiretroviral therapy. AIDS Res Hum Retroviruses. 2006;22:842-848.
11. Poynard T, Mathurin P, Lai C, et al. A comparison of fibrosis progression in chronic liver disease. J Hepatol. 2003;38:257-262.
12. Keeffe F, Dieterich D, Han S, et al. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: an update. Clin Gastroenterol Hepatol. 2006;4:936-962.
13. Lacombe K, Massari V, Girard P, et al. Major role of hepatitis B genotypes in liver fibrosis during coinfection with HIV. AIDS. 2006;20:419-427.
14. Núñez M, Soriano V. Management of patients co-infected with hepatitis B virus and HIV. Lancet Infect Dis. 2005;5:374-382.
15. Park S, Kang K, Park J, et al. Clinical efficacy of AST/ALT ratio and platelet counts as predictors of degree of fibrosis in HBV infected patients without clinically evident liver cirrhosis. Korean J Gastroenterol. 2004:43:246-251.